Synthetic Genomics Launches Vmax™ Express, a Next-Generation Protein Expression Platform for the Biotech Industry Vmax™ Express is designed to replace E. coli-based platforms for manufacturing recombinant proteins and biologic drugs

LA JOLLA, CA — January 9, 2017 — Synthetic Genomics Inc. announced today that its subsidiary, SGI-DNA, has launched Vmax™ Express, a highly advanced bacterial host organism designed for significant improvement in recombinant protein expression. Compatible with standard plasmids, antibiotics and growth media used in other bacterial protein expression systems, Vmax™ Express generates larger [...]

By |2018-03-06T23:24:22+00:00March 6th, 2018|Latest Publications|Comments Off on Synthetic Genomics Launches Vmax™ Express, a Next-Generation Protein Expression Platform for the Biotech Industry Vmax™ Express is designed to replace E. coli-based platforms for manufacturing recombinant proteins and biologic drugs